5th Annual Immuno-Oncology BD&L And Investment Forum

Published on 31 May 2019
Partner Event - Sachs Association 5th Annual Immuno-Oncology BD&L And Investment Forum - 06022019 - Feature image

Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment.

Numerous networking opportunities available via an online One-2-One meeting system with dedicated meeting facilities to make the event more transactional.

Find out more or register here

Plenary and Therapeutic Sessions Include:
  • Industry Roundtable
  • Pharma-Bio Deal-making Panel
  • Advanced Therapeutics Panel
  • Latest Advances in Cell & Gene Therapies Panel
  • Innovation Panel
  • Investor Discussion
  • China-US Partnering & Investment Panel​ ​
Confirmed Keynote Speech:
  • The Oncology Anti-Gravity Machine: Can It Keep Working?” by Roger Longman, CEO, Real Endpoints LLC
Confirmed Speakers & Chairs Include: (See the full list here)
  • Anne Altmeyer, CBO, Adicet Bio, Inc.
  • Alexis Peyroles, CEO, OSE Immunotherapeutics
  • Axel Hoos, SVP, TA Head of Oncology R&D, GlaxoSmithKline
  • Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA)
  • Biren Amin, Managing Director, Jefferies Group LLC
  • Boris Peaker, Managing Director, Biotechnology Equity Research, Cowen, Inc.
  • Brad Loncar, Private Investor, Loncar Investment, LLC
  • Carlos de Sousa, CEO, Immunicum AB
  • Chris DeRespino, Executive Director, Business Development, Amgen
  • Chris Sheldon, Head of Oncology Search & Evaluation, AstraZeneca

Presenting Opportunities:
Event: Sachs Association 5th Annual Immuno-Oncology BD&L And Investment Forum - 06022019 - image1 Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

Event: Sachs Association 5th Annual Immuno-Oncology BD&L And Investment Forum - 06022019 - image2
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about presenting, exhibition or sponsorship opportunities, please email Silvia or call +44(0)203 463 4890.

Summary

Date: 31 May, 2019
Location: Waldorf Astoria Chicago Hotel, USA
Hosted by: Sachs Association
Why: Forum brings together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment.

Click here to register or find out more.

Share this with friends and colleagues